Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...

TEL AVIV and REHOVOT, Israel, July 17, 2024 /PRNewswire/ -- ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, and Lavie Bio Ltd., a leading ag-biologicals company and ...

AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...

This expansion is in addition to the previously announced Microsoft (MSFT) for Startups program. PredicTcell, Tevogen Bio’s proprietary technology, is designed for predictive, precision T cell target ...

Jan 6 (Reuters) - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic data to discover new drug candidates to send into human ...

"CGIE (TM) is being built as future-facing infrastructure rather than a point solution," said Yusuf Henriques, Founder and CEO of IndyGeneUS Bio. "Our objective is to establish the AI×Bio Factory--the ...

As we approach the end of 2024, First Opinion is publishing a series of essays on the state of AI in medicine and biopharma. There’s more to life than protein folding. You’d be forgiven for believing ...

The Bio-Intelligence Initiative investigates how coherent and low-noise neural states observed in the human brain can serve as reference models for training emerging biocomputing and bio-artificial ...

DBT Secretary emphasizes AI and bio-manufacturing's transformative potential in life sciences, urging scientists to pursue innovative, big ideas.

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I analyze the recently announced ...